
Article 1 
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Union.
It shall apply from 24 October 2010.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 24 August 2010.
For the Commission
The President
José Manuel BARROSO
ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the following substance is inserted in alphabetical order:

Pharmacologically active substance Marker residue Animal species MRL Target tissues Other provisions(according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification
‘Tildipirosin Tildipirosin Bovine, caprine 400 μg/kg Muscle Not for use in animals from which milk is produced for human consumption.The MRL for muscle shall not apply to the injection site, where residue levels shall not exceed 11 500 μg/kg.Provisional MRL shall expire on 1 January 2012. Macrolide’
200 μg/kg Fat
2 000 μg/kg Liver
3 000 μg/kg Kidney
Porcine 1 200 μg/kg Muscle The MRL for muscle shall not apply to the injection site, where residue levels shall not exceed 7 500 μg/kg.Provisional MRL shall expire on 1 January 2012.
800 μg/kg Skin and fat
5 000 μg/kg Liver
10 000 μg/kg Kidney
